glp-1 compounding crackdown news october 2025 FDA Puts Pressure on Compounders, Telehealth Providers FDA steps up crackdown on

The numbers tell the story: 8-10% of Americans are currently using GLP-1 medications, with another 30-35% expressing interest

doi: 10.1007/978-3-319-71779-1_3 33

Our Virtual Weight Loss Program combines trusted local providers with the convenience of telehealth appointments

Some studies emphasize an important challenge in using BAT activation as therapy, since patients need to have sufficient BAT mass and activity to benefit

Because we just dont know yet exactly what the long-term outcomes are for people who become pregnant while taking these medications. One early study suggested that using GLP-1 agonists during the first trimester didnt harm fetal development